AU5095885A - Pharmaceutical preparations - Google Patents
Pharmaceutical preparationsInfo
- Publication number
- AU5095885A AU5095885A AU50958/85A AU5095885A AU5095885A AU 5095885 A AU5095885 A AU 5095885A AU 50958/85 A AU50958/85 A AU 50958/85A AU 5095885 A AU5095885 A AU 5095885A AU 5095885 A AU5095885 A AU 5095885A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical preparations
- preparations
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
- F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
- F02B1/00—Engines characterised by fuel-air mixture compression
- F02B1/02—Engines characterised by fuel-air mixture compression with positive ignition
- F02B1/04—Engines characterised by fuel-air mixture compression with positive ignition with fuel-air mixture admission into cylinder
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3438839 | 1984-10-19 | ||
DE19843438839 DE3438839A1 (en) | 1984-10-19 | 1984-10-19 | PHARMACEUTICAL PREPARATIONS |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47653/90A Division AU4765390A (en) | 1984-10-19 | 1990-01-04 | 5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals. |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5095885A true AU5095885A (en) | 1986-05-02 |
Family
ID=6248597
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU50958/85A Abandoned AU5095885A (en) | 1984-10-19 | 1985-10-18 | Pharmaceutical preparations |
AU47653/90A Abandoned AU4765390A (en) | 1984-10-19 | 1990-01-04 | 5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47653/90A Abandoned AU4765390A (en) | 1984-10-19 | 1990-01-04 | 5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0198919B1 (en) |
JP (2) | JPH0742229B2 (en) |
AU (2) | AU5095885A (en) |
DE (2) | DE3438839A1 (en) |
DK (1) | DK167531B1 (en) |
FI (1) | FI862590A (en) |
NO (1) | NO164897C (en) |
WO (1) | WO1986002268A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783591A (en) * | 1984-10-19 | 1998-07-21 | Schering Aktiengesellschaft | Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation |
US4681940A (en) * | 1985-11-19 | 1987-07-21 | American Home Products Corporation | 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles |
DE3639225A1 (en) * | 1986-11-14 | 1988-05-19 | Schering Ag | USE OF 5- (SUBST. PHENYL) -OXAZOLIDINONE DERIATES AS PSYCHOPHARMAKA |
WO1988009661A1 (en) * | 1987-06-10 | 1988-12-15 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
DE68915595T2 (en) * | 1988-03-24 | 1994-09-15 | Sankyo Co | Use of isoxazolinones as cerebroactive drugs. |
WO1992002220A1 (en) * | 1990-08-03 | 1992-02-20 | Smithkline Beecham Corporation | Tnf inhibitors |
US5124455A (en) * | 1990-08-08 | 1992-06-23 | American Home Products Corporation | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
US5547979A (en) * | 1992-03-30 | 1996-08-20 | Smithkline Beecham | TNF inhibition |
CZ290671B6 (en) * | 1995-02-10 | 2002-09-11 | Schering Aktiengesellschaft | Pharmaceutical preparations intended for inhibition of tumor necrosis factor |
DE19540475A1 (en) * | 1995-10-20 | 1997-04-24 | Schering Ag | Chiral methylphenyloxazolidinones |
US6770658B2 (en) * | 1998-09-09 | 2004-08-03 | Inflazyme Pharmaceuticals Ltd. | Substituted γ-phenyl-Δ-lactams and uses related thereto |
CA2463469A1 (en) * | 2001-10-16 | 2003-04-24 | Memory Pharmaceuticals Corporation | 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
WO2004098592A1 (en) * | 2003-05-06 | 2004-11-18 | Senju Pharmaceutical Co. Ltd. | Composition containing oxazolidinone derivative |
AR057218A1 (en) | 2005-12-15 | 2007-11-21 | Astra Ab | OXAZOLIDINONE COMPOUNDS AND THEIR USE AS PONTENCIATORS OF THE METABOTROPIC GLUTAMATE RECEIVER |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2413935A1 (en) * | 1974-03-20 | 1975-10-16 | Schering Ag | 4- (POLYALCOXY-PHENYL) -2-PYRROLIDONE |
SU888821A3 (en) * | 1976-12-03 | 1981-12-07 | Шеринг Аг (Инофирма) | Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs |
DE2655369A1 (en) * | 1976-12-03 | 1978-06-08 | Schering Ag | 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION |
-
1984
- 1984-10-19 DE DE19843438839 patent/DE3438839A1/en not_active Withdrawn
-
1985
- 1985-10-18 WO PCT/DE1985/000472 patent/WO1986002268A1/en active IP Right Grant
- 1985-10-18 EP EP85905773A patent/EP0198919B1/en not_active Expired - Lifetime
- 1985-10-18 AU AU50958/85A patent/AU5095885A/en not_active Abandoned
- 1985-10-18 DE DE8585905773T patent/DE3576118D1/en not_active Expired - Lifetime
- 1985-10-18 JP JP60505152A patent/JPH0742229B2/en not_active Expired - Lifetime
-
1986
- 1986-06-17 FI FI862590A patent/FI862590A/en not_active Application Discontinuation
- 1986-06-18 NO NO862439A patent/NO164897C/en unknown
- 1986-06-19 DK DK288686A patent/DK167531B1/en not_active IP Right Cessation
-
1990
- 1990-01-04 AU AU47653/90A patent/AU4765390A/en not_active Abandoned
-
1994
- 1994-02-04 JP JP6012897A patent/JP2669494B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS62501289A (en) | 1987-05-21 |
JP2669494B2 (en) | 1997-10-27 |
EP0198919B1 (en) | 1990-02-28 |
FI862590A0 (en) | 1986-06-17 |
EP0198919A1 (en) | 1986-10-29 |
AU4765390A (en) | 1990-05-03 |
NO164897C (en) | 1990-11-28 |
NO164897B (en) | 1990-08-20 |
DK167531B1 (en) | 1993-11-15 |
WO1986002268A1 (en) | 1986-04-24 |
DK288686D0 (en) | 1986-06-19 |
DE3576118D1 (en) | 1990-04-05 |
FI862590A (en) | 1986-06-17 |
DE3438839A1 (en) | 1986-04-24 |
DK288686A (en) | 1986-06-19 |
NO862439D0 (en) | 1986-06-18 |
NO862439L (en) | 1986-06-18 |
JPH0742229B2 (en) | 1995-05-10 |
JPH0761978A (en) | 1995-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6532586A (en) | Pharmaceutical preparation | |
AU583585B2 (en) | Etoposide preparations | |
AU5142485A (en) | Cytotoxic protein | |
GB8518979D0 (en) | Pharmaceutical preparation | |
CS419991A3 (en) | Pharmaceutical preparations | |
GB8421706D0 (en) | Pharmaceutical preparations | |
AU8317587A (en) | Therapeutic preparations | |
AU4454389A (en) | Pharmaceutical composition | |
AU7756487A (en) | Pharmaceutical formulations | |
AU5095885A (en) | Pharmaceutical preparations | |
EP0207451A3 (en) | Pharmaceutical preparations | |
IL75921A0 (en) | Gelatinous pharmaceutical preparations | |
AU4280985A (en) | Dihydropyridine preparations | |
AU564632B2 (en) | Pharmaceutical iodophor preparations | |
AU589637B2 (en) | Fungicide preparations | |
AU584547B2 (en) | Pharmaceutical `` -aminoalkyl- `` -alkylphenylacetonitriles | |
ZA852279B (en) | Pharmaceutical preparations | |
GB8520189D0 (en) | Pharmaceutical preparations | |
AU4280885A (en) | Nifedipine preparations | |
AU7984487A (en) | Pharmaceutical combination | |
AU2065588A (en) | Pharmaceutical preparations for external use | |
AU6236090A (en) | Pharmaceutical preparations | |
AU587505B2 (en) | Pharmaceutical compositions | |
AU585011B2 (en) | Rioprostil-PVP complex | |
AU5676286A (en) | New medicine |